$AFYA

Afya and Yduqs, Brazil's largest medical-education network and education group, confirmed early-stage merger talks on 24 August 2026. Yduqs shares rose 12.1% in São Paulo, while Afya's shares in New York increased 0.77%. The companies' second-quarter financials showed contrasting performances, with Afya in a stronger position. No binding agreements or details have been finalized, and both companies emphasized the preliminary nature of the discussions.

Afya (AFYA) reported Q2 2026 revenue of BRL 1.985 billion, up 7% YoY. Adjusted EBITDA rose 3% to BRL 918 million, while net income increased 7% to BRL 463 million. The company faces AI competition in clinical decision tools but is integrating AI into its iClinic platform. Management reaffirmed its full-year EBITDA guidance of BRL 1.7-1.8 billion.

Afya (NASDAQ:AFYA) reported Q2 earnings call updates. Management said medical course pricing stayed favorable and health science courses grew 13% YoY. Continuing education revenue rose 5% to BRL 144 million; medical practice solutions revenue rose 2% to BRL 85 million. Operating cash flow was BRL 806 million and free cash flow to equity BRL 423 million. Full-year adjusted EBITDA guidance was kept at BRL 1.7-1.8 billion.

Afya (AFYA) reported Q2 adjusted EPS of $0.45, slightly below the Zacks Consensus of $0.46, versus $0.40 a year earlier. Revenue was $192.36 million, marginally under the estimate. The article cites a Zacks Rank #3 (Hold) and notes upcoming consensus for the next quarter at $0.41 EPS on $196.33 million revenue.

Afya Ltd (AFYA) furnished an SEC Form 6-K — earnings release. Afya Limited Announces Second-Quarter and First-Half 2026 Financial Results R$448 Million Returned to Shareholders 106% of 1H26 FCFE Distributed Through Dividends and Share Repurchases Belo Horizonte, Brazil, August 13, 2026 – Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or th

Afya Limited (Nasdaq: AFYA) announced that Marcelo Ken Suhara was appointed on July 27, 2026 as Chair Member of its Audit, Risks and Ethics Committee. He succeeds João Paulo Seibel de Faria, whose passing was noted by the company. Afya said Suhara will continue as Audit Committee financial expert and independent board member.

Junior Lelio de Souza (Vice President) sold 36,204 shares of Afya Ltd (AFYA) at $15.00 ($0.54M total) on 2026-07-01.

Basolli Gomiero Mirella (Vice President) sold 10,000 shares of Afya Ltd (AFYA) at $14.80 ($0.15M total) on 2026-06-26.

Junior Lelio de Souza (Vice President) sold 41,541 shares of Afya Ltd (AFYA) at $15.00 ($0.62M total) on 2026-06-26.

JPMorgan Chase & Co. has reduced its price target for Afya (NASDAQ:AFYA) from $22.00 to $21.50, maintaining a "neutral" rating. This new target suggests a potential upside of 49.20% from the stock's current price. Other analysts have also recently commented on Afya, with one strong buy rating, one buy rating, and six hold ratings, resulting in a consensus "Hold" rating and a price target of $17.20.